| Unique ID issued by UMIN | UMIN000063106 |
|---|---|
| Receipt number | R000072200 |
| Scientific Title | Efficacy of Intraoperative Nitrous Oxide for Chronic Postoperative Pain and the Role of Genetic Polymorphisms in Patients With Cervical Spinal Cord Injury: An Exploratory Single-Arm Prospective Interventional Study |
| Date of disclosure of the study information | 2026/09/29 |
| Last modified on | 2026/09/29 23:24:23 |
Efficacy of Intraoperative Nitrous Oxide for Chronic Postoperative Pain and the Role of Genetic Polymorphisms in Patients With Cervical Spinal Cord Injury: An Exploratory Single-Arm Prospective Interventional Study
Efficacy of Intraoperative Nitrous Oxide for Chronic Postoperative Pain and the Role of Genetic Polymorphisms in Patients With Cervical Spinal Cord Injury
Efficacy of Intraoperative Nitrous Oxide for Chronic Postoperative Pain and the Role of Genetic Polymorphisms in Patients With Cervical Spinal Cord Injury: An Exploratory Single-Arm Prospective Interventional Study
INOPPs2 study
| Japan |
Traumatic cervical spinal cord injury
| Orthopedics |
Others
YES
To clarify the association between genetic polymorphisms and chronic-phase neuropathic pain in patients receiving intraoperative Nitrous oxides.
Efficacy
Exploratory
Explanatory
Not applicable
NRS at 6 months
NRS at rest and during movement (postoperative days 1-2, 6 months, 1 year)
NRS for numbness and Neuropathic Pain Symptom Inventory (NPSI) (6 months, 1 year postoperatively);
genetic polymorphism types (C677T/A1298C)
assessment of activities of daily living (6 months, 1 year postoperatively)
patient satisfaction (6 months, 1 year postoperatively)
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
| Medicine |
Intraoperative nitrous oxide inhalation
| 20 | years-old | <= |
| Not applicable |
Male and Female
Patients aged 20 or older with cervical spinal cord injury (classified as ASIA C or D) who were transported to Saitama Medical Center and determined to require surgery.
Individuals who received a full explanation regarding participation in this study, demonstrated sufficient understanding, and provided written informed consent based on their own free will.
1) Pneumothorax or head trauma
2) Trauma to the limbs (fractures or nerve injuries)
3) Non-Japanese speakers
4) Impaired consciousness (making assessment difficult)
5) Patients already enrolled in another clinical trial
6) Comorbid psychiatric disorders (e.g., suicidal ideation)
7) Comorbid limb trauma
8) History of blood disorders
9) Patients taking NMDA receptor antagonists
10) Individuals who did not provide written informed consent
11) Individuals who withdrew consent
12) Any other individuals deemed unsuitable by the principal investigator
200
| 1st name | Takao |
| Middle name | |
| Last name | Kato |
Saitama Medial Center
Anesthesiology
3500844
1981 Kamoda, Kawagoe, Saitama 350-8550, Japan
0492283654
tkatoh@saitama-med.ac.jp
| 1st name | Takao |
| Middle name | |
| Last name | Kato |
Saitama Medial Center
Anesthesiology
3500844
1981 Kamoda, Kawagoe, Saitama 350-8550, Japan
0492283654
tkatoh@saitama-med.ac.jp
Saitama Medical School
Japan Society for the Promotion of Science, JSPS
Japanese Governmental office
Research Ethics Committee of Saitama Medical University General Medical Center
1981 Kamoda, Kawagoe, Saitama 350-8550, Japan
049-228-3902
smcrinri@saitama-med.ac.jp
NO
| 2026 | Year | 09 | Month | 29 | Day |
Unpublished
Preinitiation
| 2026 | Year | 09 | Month | 17 | Day |
| 2026 | Year | 12 | Month | 01 | Day |
| 2030 | Year | 03 | Month | 31 | Day |
| 2026 | Year | 09 | Month | 29 | Day |
| 2026 | Year | 09 | Month | 29 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072200